Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was CNY 5,923.27 million compared to CNY 1,865.57 million a year ago. Revenue was CNY 5,929.73 million compared to CNY 1,963.97 million a year ago.

Net income was CNY 2,692.94 million compared to CNY 721.51 million a year ago. Basic earnings per share from continuing operations was CNY 2.1857 compared to CNY 0.5857 a year ago. Diluted earnings per share from continuing operations was CNY 2.1857 compared to CNY 0.5857 a year ago.